Hospital In-Patient Insulin Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00135070
Recruitment Status : Terminated (No documentation with MHRA to support clinical trial of a medicinal product.)
First Posted : August 25, 2005
Last Update Posted : May 1, 2007
Information provided by:
The Royal Bournemouth Hospital

August 23, 2005
August 25, 2005
May 1, 2007
July 2005
Not Provided
Glucose control
Not Provided
Complete list of historical versions of study NCT00135070 on Archive Site
Length of stay
Not Provided
Not Provided
Not Provided
Hospital In-Patient Insulin Study
A Randomised Study Comparing Continuous Intravenous Insulin Infusion With Subcutaneous Insulin Analogues in Hospitalised Patients With Type II Diabetes and Hyperglycaemia
Hyperglycaemia has been shown to increase morbidity and mortality in patients with critical illness, myocardial infarction and stroke. This study aims to look at patients with hyperglycaemia and reduce their blood sugar levels using differing combinations of subcutaneous and intravenous insulin.
This is a randomised trial involving patients with type II diabetes who are brought into the hospital with a problem other than a diabetic emergency. Patients will be included, who have a blood sugar > than 17mmols. They will be randomised to one of two groups and either given intravenous or subcutaneous insulin. Outcome measures are length of stay, glucose control and comparison of the two regimens. Cost implications will also be analysed.
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Diabetes Mellitus, Type 2
Drug: Detemir
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
June 2006
Not Provided

Inclusion Criteria:

  • Type II diabetes
  • Blood glucose > 17mmols

Exclusion Criteria:

  • Type I diabetes
  • Hyperosmolar non-ketotic coma (HONK)
  • Diabetic ketoacidosis (DKA)
  • Myocardial infarction (MI)
  • Vomiting
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
United Kingdom
Not Provided
Not Provided
Not Provided
The Royal Bournemouth Hospital
Not Provided
Principal Investigator: David Kerr, Doctor The Royal Bournemouth Hospital
The Royal Bournemouth Hospital
April 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP